Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals

Metabolism: Clinical and Experimental

Volumn 69, Issue , 2017, Pages 76-86

  Luthold, Renata V ^a   Fernandes, Gabriel R ^b   Franco de Moraes, Ana Carolina ^a   Folchetti, Luciana G D ^a   Ferreira, Sandra Roberta G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Gram negative bacteria; Gut microbiota; Inflammation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; VITAMIN D; HYDROXYCOLECALCIFEROL; IMMUNOLOGIC FACTOR; RNA 16S; VITAMIN;

ACTINOBACTERIA; ADULT; AGE; ARTICLE; BACTEROIDETES; BODY MASS; CROSS-SECTIONAL STUDY; DAIRY PRODUCT; FAECALIBACTERIUM; FECES MICROFLORA; FEMALE; FIRMICUTES; HAEMOPHILUS; HUMAN; IMMUNOMODULATION; INFLAMMATION; INTESTINE FLORA; MALE; MEGASPHAERA; MILK; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PREVOTELLA; PRIORITY JOURNAL; PROTEOBACTERIA; SEASONAL VARIATION; SEX DIFFERENCE; VEILLONELLA; VERRUCOMICROBIA; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; YOUNG ADULT; ANTHROPOMETRY; BLOOD; BLOOD PRESSURE; DIET; EXERCISE; FECES; IMMUNOLOGY; METABOLIC DISORDER; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; REFERENCE VALUE;

ADULT; ANTHROPOMETRY; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIET; EXERCISE; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; HYDROXYCHOLECALCIFEROLS; IMMUNOLOGIC FACTORS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; METABOLIC DISEASES; REFERENCE VALUES; RNA, RIBOSOMAL, 16S; VITAMIN D; VITAMINS; YOUNG ADULT;

EID: 85009843346     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2017.01.007     Document Type: Article

References (60)

1. [1] Vieth, R., Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:5 (1999), 842–856.
2. [2] Nesby-O'Dell, S., Scanlon, K.S., Cogswell, M.E., Gillespie, C., Hollis, B.W., Looker, A.C., et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 76:1 (2002), 187–192.
3. [3] Hollis, B.W., Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135:2 (2005), 317–322.
4. [4] Hyppönen, E., Power, C., Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85:3 (2007), 860–868.
5. [5] Wang, T.J., Pencina, M.J., Booth, S.L., Jacques, P.F., Ingelsson, E., Lanier, K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:4 (2008), 503–511, 10.1161/CIRCULATIONAHA.107.706127.
6. [6] Salehpour, A., Shidfar, F., Hosseinpanah, F., Vafa, M., Razaghi, M., Hoshiarrad, A., et al. Vitamin D 3 and the risk of CVD in overweight and obese women: a randomized controlled trial. Br J Nutr 108:10 (2012), 1866–1873, 10.1017/S0007114512000098.
7. [7] Hewison, M., Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 39:2 (2010), 365–379.
8. [8] Cantorna, M.T., Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol 92:1 (2006), 60–64, 10.1016/j.pbiomolbio.2006.02.020.
9. [9] Michos, E.D., Melamed, M.L., Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 11:1 (2008), 7–12, 10.1097/MCO.0b013e3282f2f4dd.
10. [10] Vaidya, A., Vitamin D and cardio-metabolic disease. Metabolism, 62(12), 2013, 1697.
11. [11] Wolden-Kirk, H., Overbergh, L., Christesen, H.T., Brusgaard, K., Mathieu, C., Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol 347:1 (2011), 106–120, 10.1016/j.mce.2011.08.016.
12. [12] Kim, H.J., Kang, C.K., Park, H., Lee, M.G., Effects of vitamin D supplementation and circuit training on indices of obesity and insulin resistance in T2D and vitamin D deficient elderly women. J Exerc Nutr Biochem, 18(3), 2014, 249, 10.5717/jenb.2014.18.3.249.
13. [13] Chiu, K.C., Chu, A., Go, V.L.W., Saad, M.F., Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr 79:5 (2004), 820–825.
14. [14] Schuch, N.J., Garcia, V.C., Martini, L.A., Vitamin D and endocrine diseases. Arq Bras Endocrinol Metab 53:5 (2009), 625–633.
15. [15] Norman, P.E., Powell, J.T., Vitamin D and cardiovascular disease. Circ Res 114:2 (2014), 379–393, 10.1161/CIRCRESAHA.113.301241.
16. [16] Herrmann, M., Sullivan, D.R., Veillard, A., McCorquodale, T., Straub, I.R., Scott, R., et al. Serum 25-Hydroxy vitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care 38:3 (2014), 521–528.
17. [17] Wellen, K.E., Hotamisligil, G.S., Inflammation, stress, and diabetes. J Clin Invest 115:5 (2005), 1111–1119.
18. [18] Cani, P.D., Delzenne, N.M., Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 10:6 (2007), 729–734, 10.1097/MCO.0b013e3282efdebb.
19. [19] Caricilli, A.M., Picardi, P.K., de Abreu, L.L., Ueno, M., Prada, P.O., Ropelle, E.R., et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol, 9(12), 2011, e1001212.
20. [20] Moraes, A.C.F., Silva, I.T., Almeida-Pititto, B., Ferreira, S.R.G., Microbiota intestinal e risco cardiometabólico: mecanismos e modulação dietética. Arq Bras Endocrinol Metab 58:4 (2014), 317–327, 10.1590/0004-2730000002940.
21. [21] Ridker, P.M., Buring, J.E., Shih, J., Matias, M., Hennekens, C.H., Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:8 (1998), 731–733, 10.1161/01.CIR.98.8.731.
22. [22] Calder, P.C., Ahluwalia, N., Albers, R., Bosco, N., Bourdet-Sicard, R., Haller, D., et al. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br J Nutr 109:S1 (2013), S1–S34, 10.1017/S0007114512005119.
23. [23] Almeida-Pititto, B., Ribeiro-Filho, F.F., Bittencourt, M.S., Lotufo, P.A., Bensenor, I., Ferreira, S.R., Usefulness of circulating E-selectin to early detection of the atherosclerotic process in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Diabetol Metab Syndr, 8(19), 2016, 10.1186/s13098-016-0133-9.
24. [24] Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. PNAS 110:22 (2013), 9066–9071, 10.1073/pnas.1219451110.
25. [25] Kong, J., Zhang, Z., Musch, M.W., Ning, G., Sun, J., Hart, J., et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 294 (2008), G208–G216, 10.1152/ajpgi.00398.2007.
26. [26] Ooi, J.H., Li, Y., Rogers, C.J., Cantorna, M.T., Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr 143:10 (2013), 1679–1686.
27. 3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. Eur J Nutr 55 (2015), 1479–1489, 10.1007/s00394-015-0966-2.
28. [28] Mai, V., McCrary, Q.M., Sinha, R., Glei, M., Associations between dietary habits and body mass index with gut microbiota composition and fecal water genotoxicity: an observational study in African American and Caucasian American volunteers. Nutr J, 8(1), 2009, 49, 10.1186/1475-2891-8-49.
29. [29] Ly, N.P., Litonjua, A., Gold, D.R., Celedón, J.C., Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity?. J Allergy Clin Immunol 127:5 (2011), 1087–1094, 10.1016/j.jaci.2011.02.015.
30. [30] Ciubotaru, I., Green, S.J., Kukreja, S., Barengolts, E., Significant differences in fecal microbiota are associated with various stages of glucose tolerance in African American male veterans. Transl Res 166:5 (2015), 401–411, 10.1016/j.trsl.2015.06.015.
31. [31] Folchetti, L.G.D., da Silva, I.T., de Almeida-Pititto, B., Ferreira, S.R.G., Nutritionists’ Health Study cohort: a web-based approach of life events, habits and health outcomes. BMJ Open, 6(8), 2016, e012081, 10.1136/bmjopen-2016-012081.
32. [32] Guyton, A.C., Hall, J.E., Textbook of medical physiology. 11th ed., 2006, Saunders, Philadelphia.
33. [33] Matsudo, S., Araújo, T., Marsudo, V., Andrade, D., Andrade, E., Braggion, G., Questinário internacional de atividade f1sica (IPAQ): estudo de validade e reprodutibilidade no Brasil. Rev Bras Ativ Fís Saúde 6:2 (2001), 05–18.
34. [34] Craig, C.L., Marshall, A.L., Sjöström, M., Bauman, A.E., Booth, M.L., Ainsworth, B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:8 (2003), 1381–1395, 10.1249/01.MSS.0000078924.61453.FB.
35. [35] Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., Gordon, C.M., Hanley, D.A., Heaney, R.P., et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:7 (2011), 1911–1930, 10.1210/jc.2011-0385.
36. [36] Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C., Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419, 10.1007/BF00280883.
37. [37] Caporaso, J.G., Lauber, C.L., Walters, W., Berg-Lyons, D., Huntley, J., Fierer, N., et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 6:8 (2012), 1621–1624, 10.1038/ismej.2012.8.
38. [38] Forman, J.P., Giovannucci, E., Holmes, M.D., Bischoff-Ferrari, H.A., Tworoger, S.S., Willett, W.C., et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49:5 (2007), 1063–1069, 10.1161/HYPERTENSIONAHA.107.087288.
39. [39] Shankar, A., Sabanayagam, C., Kalidindi, S., Serum 25-hydroxyvitamin D levels and prediabetes among subjects free of diabetes. Diabetes Care 34:5 (2011), 1114–1119, 10.2337/dc10-1203.
40. 3 supplementation on body fat mass in healthy overweight and obese women. Nutr J, 11(1), 2012, 78, 10.1201/b16308-3.
41. 3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium induced colitis 2. Am J Physiol Gastrointest Liver Physiol 309:9 (2015), G730–G742.
42. [42] Jorde, R., Sollid, S.T., Svartberg, J., Schirmer, H., Joakimsen, R.M., Njølstad, I., et al. Vitamin D 20 000 IU per week for five years does not prevent progression from prediabetes to diabetes. J Clin Endocrinol Metab 101:4 (2016), 1647–1655, 10.1210/jc.2015-4013.
43. [43] Mora, J.R., Iwata, M., von Andrian, U.H., Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 8:9 (2008), 685–698, 10.1038/nri2378.
44. [44] Hewison, M., An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 76 (2012), 315–325, 10.1111/j.1365-2265.2011.04261.x.
45. [45] Bellia, A., Garcovich, C., D'Adamo, M., Lombardo, M., Tesauro, M., Donadel, G., et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 8:1 (2013), 33–40, 10.1007/s11739-011-0559-x.
46. [46] Mellenthin, L., Wallaschofski, H., Grotevendt, A., Völzke, H., Nauck, M., Hannemann, A., Association between serum vitamin D concentrations and inflammatory markers in the general adult population. Metab Clin Exp 63:8 (2014), 1056–1062.
47. [47] Cantorna, M.T., McDaniel, K., Bora, S., Chen, J., James, J., Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease. Exp Biol Med 239:11 (2014), 1524–1530, 10.1177/1535370214523890.
48. [48] Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D.R., et al. Enterotypes of the human gut microbiome. Nature 473 (2011), 174–180.
49. [49] Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:7418 (2012), 55–60, 10.1038/nature11450.
50. [50] Wu, G.D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.Y., Keilbaugh, S.A., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334:6052 (2011), 105–108, 10.1126/science.1208344.
51. [51] Said, H.S., Suda, W., Nakagome, S., Chinen, H., Oshima, K., Kim, S., et al. Dysbiosis of salivary microbiota in inflammatory bowel disease and its association with oral immunological biomarkers. DNA Res, 037, 2013, 10.1093/dnares/dst037.
52. [52] Van den Bogert, B., Meijerink, M., Zoetendal, E.G., Wells, J.M., Kleerebezem, M., Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota. PLoS One, 9(12), 2014, e114277, 10.1371/journal.pone.0114277.
53. [53] Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L.G., Gratadoux, J.J., et al. Faecalibacterium prausnitziiisan anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105 (2008), 16731–16736.
54. [54] Collado, M.C., Isolauri, E., Laitinen, K., Salminen, S., Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 88:4 (2008), 894–899.
55. [55] Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 61 (2010), 69–78, 10.1007/s00284-010-9582-9.
56. [56] Cantarel, B.L., Waubant, E., Chehoud, C., Kuczynski, J., DeSantis, T.Z., Warrington, J., et al. Gut microbiota in multiple sclerosis. J Invest Med 63:5 (2015), 729–734, 10.1097/JIM.0000000000000192.
57. [57] Zhang, Y., Leung, D.Y., Richers, B.N., Liu, Y., Remigio, L.K., Riches, D.W., et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol 188:5 (2012), 2127–2135, 10.4049/jimmunol.1102412.
58. [58] Cantorna, M.T., Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc 69:03 (2010), 286–289, 10.1017/S0029665110001722.
59. [59] Mangin, M., Sinha, R., Fincher, K., Inflammation and vitamin D: the infection connection. Inflamm Res 63:10 (2014), 803–819, 10.1007/s00011-014-0755-z.
60. [60] Assa, A., Vong, L., Pinnell, L.J., Avitzur, N., Johnson-Henry, K.C., Sherman, P.M., Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation. J Infect Dis 210 (2014), 1296–1305, 10.1093/infdis/jiu235.